Cronos (CRON) Cash & Current Investments (2016 - 2026)
Cronos' (CRON) quarterly Cash & Current Investments came in at $821.9 million in Q1 2026, down 1.91% year-on-year from $837.8 million in Q1 2025, and down 1.19% quarter-over-quarter from $831.8 million in Q4 2025.
Cronos (CRON) Cash & Current Investments (2016 - 2026) Analysis & Trends
Cronos' Cash & Current Investments history runs 11 years deep, the most recent figure standing at $821.9 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 1.91% year-over-year to $821.9 million in Q1 2026; TTM through Mar 2026 was $821.9 million, a 1.91% decrease from a year earlier, with the FY2025 full-year figure at $831.8 million, down 3.15% from the prior year.
- Cash & Current Investments declined to $821.9 million in Q1 2026 per CRON's latest filing, from $831.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $981.5 million in Q1 2022 and bottomed at $821.9 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $848.2 million (2024), against an average of $861.5 million.
- Across the five-year window, Cash & Current Investments fell 20.81% in 2022 and gained 2.68% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $877.7 million in 2022, then fell by 1.84% to $861.5 million in 2023, then slipped by 0.32% to $858.8 million in 2024, then fell by 3.15% to $831.8 million in 2025, then retreated by 1.19% to $821.9 million in 2026.
- Per Business Quant, the three latest CRON Cash & Current Investments figures stand at $821.9 million (Q1 2026), $831.8 million (Q4 2025), and $824.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Cronos | 1.07 Bn | 251.77 Mn | 19.15 Mn | 821.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 821.86 Mn |
| Dec 31, 2025 | 831.79 Mn |
| Sep 30, 2025 | 824.17 Mn |
| Jun 30, 2025 | 834.42 Mn |
| Mar 31, 2025 | 837.82 Mn |
| Dec 31, 2024 | 858.81 Mn |
| Sep 30, 2024 | 862.03 Mn |
| Jun 30, 2024 | 848.19 Mn |
| Mar 31, 2024 | 855.11 Mn |
| Dec 31, 2023 | 861.53 Mn |
| Sep 30, 2023 | 839.56 Mn |
| Jun 30, 2023 | 840.94 Mn |
| Mar 31, 2023 | 836.43 Mn |
| Dec 31, 2022 | 877.72 Mn |
| Sep 30, 2022 | 888.75 Mn |
| Jun 30, 2022 | 944.90 Mn |
| Mar 31, 2022 | 981.47 Mn |
| Dec 31, 2021 | 997.37 Mn |
| Sep 30, 2021 | 1.04 Bn |
| Jun 30, 2021 | 1.10 Bn |